At one of end of the spectrum are distal cancers with a CIN phenotype, whilst more proximally MSI-H cancers, cancers with mucinous histology and tumours with activating B-Raf mutations are more likely to be found (see Figures 2 and 3). This evidence concerns the gene BRAF and cancer.